Jianmin Pharmaceutical GroupLtd Balance Sheet Health
Financial Health criteria checks 5/6
Jianmin Pharmaceutical GroupLtd has a total shareholder equity of CN¥2.4B and total debt of CN¥150.9M, which brings its debt-to-equity ratio to 6.3%. Its total assets and total liabilities are CN¥4.2B and CN¥1.8B respectively. Jianmin Pharmaceutical GroupLtd's EBIT is CN¥164.3M making its interest coverage ratio -0.7. It has cash and short-term investments of CN¥1.1B.
Key information
6.3%
Debt to equity ratio
CN¥150.89m
Debt
| Interest coverage ratio | -0.7x |
| Cash | CN¥1.06b |
| Equity | CN¥2.41b |
| Total liabilities | CN¥1.80b |
| Total assets | CN¥4.21b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 600976's short term assets (CN¥2.7B) exceed its short term liabilities (CN¥1.7B).
Long Term Liabilities: 600976's short term assets (CN¥2.7B) exceed its long term liabilities (CN¥80.6M).
Debt to Equity History and Analysis
Debt Level: 600976 has more cash than its total debt.
Reducing Debt: 600976's debt to equity ratio has increased from 0% to 6.3% over the past 5 years.
Debt Coverage: 600976's debt is well covered by operating cash flow (136.7%).
Interest Coverage: 600976 earns more interest than it pays, so coverage of interest payments is not a concern.